Literature DB >> 18664874

Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane.

Christine Nguyen1, Noel R Rose, Dolores B Njoku.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18664874      PMCID： PMC2746329          DOI： 10.1097/MPG.0b013e3181709fee

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN： 0277-2116            Impact factor:   2.839


× No keyword cloud information.
  19 in total

1.  Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism - a comparison with patients with overt hypothyroidism.

Authors:  L M Silva; J Chavez; M H B Canalli; C R Zanetti
Journal:  Horm Res       Date:  2003

Review 2.  Hapten carrier conjugates associated with halothane hepatitis.

Authors:  L R Pohl; D Thomassen; N R Pumford; L E Butler; H Satoh; V J Ferrans; A Perrone; B M Martin; J L Martin
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

Review 3.  Neoantigens associated with halothane hepatitis.

Authors:  L R Pohl; J G Kenna; H Satoh; D Christ; J L Martin
Journal:  Drug Metab Rev       Date:  1989       Impact factor: 4.518

4.  Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists.

Authors:  Dolores B Njoku; Robert S Greenberg; Mohammed Bourdi; Craig B Borkowf; Elizabeth M Dake; Jackie L Martin; Lance R Pohl
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

5.  Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

Authors:  M Bourdi; W Chen; R M Peter; J L Martin; J T Buters; S D Nelson; L R Pohl
Journal:  Chem Res Toxicol       Date:  1996 Oct-Nov       Impact factor: 3.739

6.  Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.

Authors:  J G Kenna; J L Martin; H Satoh; L R Pohl
Journal:  Drug Metab Dispos       Date:  1990 Sep-Oct       Impact factor: 3.922

7.  Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury.

Authors:  D Njoku; M J Laster; D H Gong; E I Eger; G F Reed; J L Martin
Journal:  Anesth Analg       Date:  1997-01       Impact factor: 5.108

Review 8.  Halothane hepatitis in children.

Authors:  J G Kenna; J Neuberger; G Mieli-Vergani; A P Mowat; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

9.  Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis.

Authors:  J L Martin; G F Reed; L R Pohl
Journal:  Biochem Pharmacol       Date:  1993-10-05       Impact factor: 5.858

10.  Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.

Authors:  E Eliasson; J G Kenna
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436
View more
  3 in total

Review 1.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a review.

Authors:  Dolores B Njoku
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-05       Impact factor: 4.481

2.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

Review 3.  Drug-induced hepatotoxicity: metabolic, genetic and immunological basis.

Authors:  Dolores B Njoku
Journal:  Int J Mol Sci       Date:  2014-04-22       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.